section name header
Index
Alendronate for the Primary and Secondary Prevention of Osteoporotic Fractures in Postmenopausal Women
Bisphosphonates in the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Bisphosphonate Therapy for Children and Adolescents with Secondary Osteoporosis
Cochrane review
Effects of Continuing or Stopping Alendronate after 5 Years of Treatment
Endocrinology
Evidence summary
Female
Internal medicine
Interventions for Decreased Bone Mineral Density Associated with HIV Infection
Osteoporosis
Osteoporosis - Related Resources
Pharmacological Glucocorticoid Treatment
Systematic review